S. Mahil

Vaccine hesitancy and access to psoriasis care during the COVID‐19 pandemic: findings from a global patient‐reported cross‐sectional survey

L. Naldi, J. Kelly, P. Di Meglio, 2022, medRxiv.

Describing the burden of the COVID‐19 pandemic in people with psoriasis: findings from a global cross‐sectional study

L. Naldi, N. Dand, F. Capon, 2021, medRxiv.

Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey*

L. Naldi, S. Langan, I. Bruce, 2020, medRxiv.

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations

P. Gisondi, K. Reich, E. D. De Jong, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations

P. Gisondi, K. Reich, E. D. De Jong, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.